The endocannabinoid system (ECS) is vital in maintaining emotional balance, stress regulation, and reward processing. Chronic substance use disrupts this system, altering the function of cannabinoid receptors and the production of endocannabinoids. For example, excessive cannabis use desensitizes the CB1 receptor, leading to reduced natural reward responses and increased cravings. Similarly, other substances indirectly affect the ECS by impairing its interaction with neurotransmitter systems. This dysregulation contributes to withdrawal symptoms, heightened stress sensitivity, and difficulty sustaining sobriety. Emerging therapies aim to restore ECS function using receptor modulators, dietary changes, and physical activities that promote endocannabinoid balance. Understanding the ECS’s role in addiction provides a promising direction for personalized treatments that target the biological underpinnings of dependency. Such interventions can improve emotional stability, reduce relapse rates, and support long-term recovery.
Title : Tailoring biblio-poetry therapies using AI and biofeedback for addiction treatment
Nile Stanley, University of North Florida, United States
Title : Clinical pharmacology of marijuana: Update 2024
Frederick J Goldstein, Philadelphia College of Osteopathic Medicine, United States
Title : Gangstalking is real, should be studied
Sam Vaknin, Southern Federal University, United Kingdom
Title : Decoding aggression, violence, and substance use in adolescents with conduct disorders: Neurochemical pathways and interventions
Ann Marie Leonard Zabel, Curry College, United States
Title : Sensoria driven genetic decoupling and impaired areal integration in diseases of agency
Denis Larrivee, University of Navarra, Spain
Title : Positive outcome of adherence to the reward deficiency syndrome solution system treatment plan: A longitudinal study
Elizabeth Dale Gilley, The Elle Foundation, United States